Share this story:

Castlecap Announces Termination of the Proposed Qualifying Transaction with Laiva Gold



 

October 23, 2024 – Calgary, Alberta – TheNewswire - CastleCap Capital Inc. (TSXV: CSTL.P) (the "Company") announces the termination of the non-binding letter of intent with Laiva Gold Inc. ("Laiva") dated July 10, 2024 and amended on September 30, 2024  The Company has agreed to accept 250,000 Laiva shares and 250,000 Laiva share purchase warrants, exercisable for two years at $1.00 per share, as settlement of the Laiva $200,000 break fee.

 

About CastleCap Capital Inc.

 

The Company is a capital pool company created pursuant to the policies of the TSXV. The Company has not commenced operations and has no assets other than cash. The Company’s principal business is the identification and evaluation of assets or businesses with a view to completing a "Qualifying Transaction" under the Policy. As of the date hereof the Company has 4,000,000 Common Shares issued and outstanding and 400,000 options exercisable on or before June 12, 2029 at a price of $0.10 per Common Share.

 

Further Information

  

For further information please contact:

 

CastleCap Capital Inc.                                       

Charles Chebry                                               

Director, President, Chief Executive Officer and Secretary       

Email: charleschebry@outlook.com                       

Telephone: (403) 680-8511                               

 

Cautionary Statements

 

This news release contains forward-looking statements and forward-looking information (collectively, "forward-looking statements") within the meaning of applicable securities laws. Any statements that are contained in this news release that are not statements of historical fact may be deemed to be forward- looking statements. Forward-looking statements are often identified by terms such as "may", "should", "anticipate", "will", "estimates", "believes", "intends" "expects" and similar expressions which are intended to identify forward-looking statements. Readers are further cautioned not to place undue reliance on any forward-looking statements, as such information, although considered reasonable by the respective management of the Parties at the time of preparation, may prove to be incorrect and actual results may differ materially from those anticipated.

 

The forward-looking statements contained in this news release are made as of the date of this news release, and are expressly qualified by the foregoing cautionary statement. Except as expressly required by securities law, the Company does not undertake any obligation to update publicly or to revise any of the included forward-looking statements, whether as a result of new information, future events or otherwise.

 

The TSX Venture Exchange Inc. has neither approved nor disapproved the contents of this news release.

 

This news release shall not constitute an offer to sell or the solicitation of an offer to buy any securities in any jurisdiction.

 

This news release does not constitute an offer to sell or a solicitation of an offer to buy the securities described herein in the United States or in any other jurisdiction, nor shall there be any sale of the securities in any state in which such offer, solicitation or sale would be unlawful. The securities have not been and will not be registered under the U.S. Securities Act, or any state securities laws, and accordingly, may not be offered or sold in the United States except in compliance with the registration requirements of the U.S. Securities Act and applicable state securities requirements or pursuant to exemptions therefrom.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this news release. No stock exchange, securities commission or other regulatory authority has approved or disapproved the information contained herein.

 

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES